Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07279259
Recruiting
Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management
Phase 2 · China · 1 site
Registry update: 21 Jan 2026
NCT07349303
Recruiting
Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma
Phase 2 · Sweden · 1 site
Registry update: 26 Aug 2026
NCT07223541
Recruiting
Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma
Phase 2 · United States · 1 site
Registry update: 2 Mar 2026
NCT07348705
Recruiting
Electrophysiology-based DBS Programming for PD
Not applicable · United States · 1 site
Registry update: 30 Mar 2026
NCT07195682
Recruiting
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Phase 1 · Canada, Spain, France, Italy, United States · 13 sites
Registry update: 11 Aug 2026
NCT07465224
Recruiting
A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus
Phase 2 · United States · 1 site
Registry update: 20 Oct 2026
NCT06837480
Recruiting
Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema
Not applicable · United States · 2 sites
Registry update: 23 Jun 2026
NCT07585409
Recruiting
Physical Activity in Persons With Parkinson's Disease
Not applicable · Sweden · 1 site
Registry update: 15 May 2026
NCT07597798
Recruiting
EVERiST: Impact of Image Detected Accessory Pudendal Artery on Erection Recovery After Nerve Sparing Prostatectomy
Not applicable · United Kingdom · 1 site
Registry update: 19 May 2026
NCT07653347
Recruiting
Infant RSV Immunity Study
Not applicable · Canada · 1 site
Registry update: 17 Jun 2026
2024-519798-20-00
Recruiting
Phase II randomized trial of XELOX plus DoSTARlimab versus XELOX alone as Consolidation Treatment after Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients – IMMUNOSTAR Trial - GOIRC-02-2024
Phase 2 · Italy · 30 sites
Registry update: 23 Dec 2025
NCT07381257
Recruiting
Efficacy and Safety of Rifaximin-α in Treating MASLD
Early phase 1 · China · 1 site
Registry update: 2 Feb 2026
NCT07611721
Recruiting
Evaluate the Performance of the Dexcom G7 Continuous Glucose Monitoring (CGM) System in Critically Ill Patients Undergoing Major Abdominal Surgery and Solid Organ Transplantation Which Require Blood Glucose Monitoring for Intensive Insulin Therapy.
Not applicable · Czechia · 1 site
Registry update: 28 May 2026
NCT07249346
Recruiting
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
Phase 2 · United States · 3 sites
Registry update: 2 Sept 2026
NCT07851779
Recruiting
Withdrawal of Heart Failure Treatment Patients With Non-ischemic Cardiomyopathy Who Have Been Super-responders to Cardiac Resynchronization Therapy.
Phase 4 · Spain · 4 sites
Registry update: 1 Oct 2026
NCT07027995
Recruiting
Food and Fitness With Medicine (FFWM)
Not applicable · United States · 4 sites
Registry update: 23 Feb 2026
NCT07561957
Recruiting
A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
Not applicable · Ireland · 2 sites
Registry update: 1 May 2026
NCT07317934
Recruiting
Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)
Phase 3 · China · 36 sites
Registry update: 6 Aug 2026
NCT06957691
Recruiting
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Phase 2 · United States · 1 site
Registry update: 17 Aug 2026
NCT07361640
Recruiting
DiaMester Pilot RCT: E-health Lifestyle Program for Type 2 Diabetes
Not applicable · Norway · 1 site
Registry update: 23 Jan 2026

Ordered by registry start date. Freshness and sponsorship never change the order.